Sigma-Aldrich to sell coagulation business to Trinity Biotech
Executive Summary
Life science research supplier Sigma-Aldrich signed a letter of intent to sell its coagulation products to Irish immunoassay diagnostics company Trinity Biotech.
Deal Industry
- Biotechnology
- In Vitro Diagnostics
-
In Vitro Diagnostics
- Hematology, Coagulation
Deal Status
- Preliminary
Deal Type
-
Alliance
- Marketing (Licensing)
- Product Purchase
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice